Export

Streptokinase
Essential medicine status
General description
Streptokinase is a enzyme produced by beta-hemolytic streptococcus used as a thrombolytic agent for the treatment of acute myocardial infarction.
INN
Streptokinase
Medicine type
Chemical agent
EML status history
First added in 1991 (TRS 825) for Acute myocardial infarction
Therapeutic equivalent for
Wikipedia
Recommendations
Section
Thrombolytic medicines
  • Parenteral > General injections > IV: 1.5 million IU in vial powder for injection